TY - JOUR
T1 - Focal gray matter changes in schizophrenia across the course of the illness
T2 - A 5-year follow-up study
AU - Van Haren, Neeltje E.M.
AU - Hulshoff Pol, Hilleke E.
AU - Schnack, Hugo G.
AU - Cahn, Wiepke
AU - Mandl, René C.W.
AU - Collins, D. Louis
AU - Evans, Alan C.
AU - Kahn, René S.
PY - 2007/10
Y1 - 2007/10
N2 - Recent volumetric magnetic resonance imaging (MRI) studies have suggested brain volume changes in schizophrenia to be progressive in nature. Whether this is a global process or some brain areas are more affected than others is not known. In a 5-year longitudinal study, MRI whole brain scans were obtained from 96 patients with schizophrenia and 113 matched healthy comparison subjects. Changes over time in focal gray and white matter were measured with voxel-based morphometry throughout the brain. Over the 5-year interval, excessive decreases in gray matter density were found in patients in the left superior frontal area (Brodmann areas 9/10), left superior temporal gyrus (Brodmann area 42), right caudate nucleus, and right thalamus as compared to healthy individuals. Excessive gray matter density decrease in the superior frontal gray matter was related to increased number of hospitalizations, whereas a higher cumulative dose of clozapine and olanzapine during the scan interval was related to lesser decreases in this area. In conclusion, gray matter density loss occurs across the course of the illness in schizophrenia, predominantly in left frontal and temporal cortices. Moreover, the progression in left frontal density loss appears to be related to an increased number of psychotic episodes, with atypical antipsychotic medication attenuating these changes.
AB - Recent volumetric magnetic resonance imaging (MRI) studies have suggested brain volume changes in schizophrenia to be progressive in nature. Whether this is a global process or some brain areas are more affected than others is not known. In a 5-year longitudinal study, MRI whole brain scans were obtained from 96 patients with schizophrenia and 113 matched healthy comparison subjects. Changes over time in focal gray and white matter were measured with voxel-based morphometry throughout the brain. Over the 5-year interval, excessive decreases in gray matter density were found in patients in the left superior frontal area (Brodmann areas 9/10), left superior temporal gyrus (Brodmann area 42), right caudate nucleus, and right thalamus as compared to healthy individuals. Excessive gray matter density decrease in the superior frontal gray matter was related to increased number of hospitalizations, whereas a higher cumulative dose of clozapine and olanzapine during the scan interval was related to lesser decreases in this area. In conclusion, gray matter density loss occurs across the course of the illness in schizophrenia, predominantly in left frontal and temporal cortices. Moreover, the progression in left frontal density loss appears to be related to an increased number of psychotic episodes, with atypical antipsychotic medication attenuating these changes.
KW - Antipsychotic medication
KW - Follow-up
KW - Frontal lobe
KW - MRI
KW - Schizophrenia
KW - Voxel-based morphometry
UR - http://www.scopus.com/inward/record.url?scp=34548671937&partnerID=8YFLogxK
U2 - 10.1038/sj.npp.1301347
DO - 10.1038/sj.npp.1301347
M3 - Article
C2 - 17327887
AN - SCOPUS:34548671937
SN - 0893-133X
VL - 32
SP - 2057
EP - 2066
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 10
ER -